BCL3 is known as a transcription factor associated with the activity of NF‐κB concerning the inflammatory response in pancreatic and biliary tissues.26 However, future researches are required regarding the regulatory possibility of the NF‐κB signalling pathway in ovarian cancer. The gene discussed is BCL3; the disease is ovarian cancer.